Putnam Investments LLC Catalyst Pharmaceuticals, Inc. Transaction History
Putnam Investments LLC
- $73 Billion
- Q4 2023
A detailed history of Putnam Investments LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 26,498 shares of CPRX stock, worth $621,378. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,498
Previous 29,983
11.62%
Holding current value
$621,378
Previous $350,000
27.14%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CPRX
# of Institutions
312Shares Held
98.5MCall Options Held
29.2KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$438 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY9.13MShares$214 Million2.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.1MShares$190 Million0.0% of portfolio
-
State Street Corp Boston, MA6.03MShares$141 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.02MShares$70.8 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.41B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...